Ashburton (Jersey)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$6K Hold
300
﹤0.01% 51
2023
Q3
$8K Hold
300
﹤0.01% 50
2023
Q2
$8K Buy
+300
New +$7.55K ﹤0.01% 50

Other funds holding TDOC

Ashburton (Jersey)'s TDOC Position: Q4 2023 in Review

Ashburton (Jersey) held its Teladoc Health (TDOC) position steady in Q4 2023 at 300 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #51.

Ashburton (Jersey) first reported a position in TDOC in Q2 2023 and has held it in 3 quarters since. The position peaked at $8K in Q3 2023. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Ashburton (Jersey) held 300 shares of Teladoc Health worth $6K as of Q4 2023.
  • Ashburton (Jersey) left its Teladoc Health share count unchanged in Q4 2023.
  • Teladoc Health made up ﹤0.01% of Ashburton (Jersey)'s portfolio in Q4 2023, its #51 holding.
  • Ashburton (Jersey) first reported a position in Teladoc Health in Q2 2023 and has held it in 3 quarters since.
  • Ashburton (Jersey)'s Teladoc Health position peaked at $8K in Q3 2023.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Ashburton (Jersey)'s 13F filing for Q4 2023, filed 6 Feb 2024.